LightPath Technologies (LPTH) Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LightPath Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" LPTH shares.
View LPTH analyst ratings or view top-rated stocks.

1 analysts have issued twelve-month target prices for LightPath Technologies' shares. Their LPTH share price forecasts range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 98.7% from the stock's current price.
View analysts price targets for LPTH or view top-rated stocks among Wall Street analysts.

LightPath Technologies' stock was trading at $1.22 at the beginning of 2023. Since then, LPTH shares have increased by 23.8% and is now trading at $1.51.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 13th 2023.
View our LPTH earnings forecast.

LightPath Technologies, Inc. (NASDAQ:LPTH) released its quarterly earnings data on Thursday, November, 4th. The technology company reported ($0.02) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.02). The technology company earned $9.10 million during the quarter, compared to analysts' expectations of $8.79 million. LightPath Technologies had a negative net margin of 14.30% and a negative trailing twelve-month return on equity of 15.01%. During the same quarter last year, the business earned $0.01 earnings per share.

3 employees have rated LightPath Technologies Chief Executive Officer Jim Gaynor on Glassdoor.com. Jim Gaynor has an approval rating of 65% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other LightPath Technologies investors own include EXFO (EXFO), RTI Surgical (RTIX), Merit Medical Systems (MMSI), Pfizer (PFE), Advanced Micro Devices (AMD), Pixelworks (PXLW), Kopin (KOPN), Palatin Technologies (PTN), Sorrento Therapeutics (SRNE) and Micron Technology (MU).

LightPath Technologies trades on the NASDAQ under the ticker symbol "LPTH."

LightPath Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include AIGH Capital Management LLC (9.11%), AMH Equity Ltd (6.02%), Royce & Associates LP (3.39%), Royce & Associates LP (3.33%), Relyea Zuckerberg Hanson LLC (2.81%) and Renaissance Technologies LLC (2.02%). Insiders that own company stock include Albert Miranda, Darcie Peck, Louis Leeburg, Shmuel Rubin and Steven E Creviston.
View institutional ownership trends.

Shares of LPTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LPTH stock can currently be purchased for approximately $1.51.

LightPath Technologies (NASDAQ:LPTH) has a market capitalization of $56.37 million and generates $35.56 million in revenue each year. The technology company earns $-3,540,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis.

The company employs 353 workers across the globe.

LightPath Technologies' mailing address is 2603 CHALLENGER TECH CT SUITE 100, ORLANDO FL, 32826. The official website for the company is www.lightpath.com. The technology company can be reached via phone at (407) 382-4003 or via fax at 407-382-4007.